Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln
25/08/2026 10:54
BRIEF-WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln Aug 25 (Reuters) - WuXi Biologics H1 net income attributable RMB 2,439.8 million.
- H1 revenue RMB 11,787.2 million
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln